Erik J.M. van Bommel

1.8k total citations · 2 hit papers
19 papers, 1.2k citations indexed

About

Erik J.M. van Bommel is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Erik J.M. van Bommel has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Erik J.M. van Bommel's work include Diabetes Treatment and Management (12 papers), Chronic Kidney Disease and Diabetes (9 papers) and Pancreatic function and diabetes (4 papers). Erik J.M. van Bommel is often cited by papers focused on Diabetes Treatment and Management (12 papers), Chronic Kidney Disease and Diabetes (9 papers) and Pancreatic function and diabetes (4 papers). Erik J.M. van Bommel collaborates with scholars based in Netherlands, United States and Canada. Erik J.M. van Bommel's co-authors include Daniël H. van Raalte, Marcel H.A. Muskiet, Lennart Tonneijck, Jaap A. Joles, Mark M. Smits, Hiddo J.L. Heerspink, Max Nieuwdorp, Mark H.H. Kramer, Daan J. Touw and A.H. Jan Danser and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Erik J.M. van Bommel

18 papers receiving 1.2k citations

Hit Papers

Glomerular Hyperfiltratio... 2017 2026 2020 2023 2017 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
    2017 595 citations Lennart Tonneijck, Marcel H.A. Muskiet et al. Journal of the American Society of Nephrology profile →
  2. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
    2019 253 citations Erik J.M. van Bommel, Marcel H.A. Muskiet et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik J.M. van Bommel Netherlands 9 712 432 345 298 160 19 1.2k
Heidrun Bosch‐Traberg Denmark 14 1.2k 1.7× 196 0.5× 425 1.2× 462 1.6× 102 0.6× 25 1.5k
Jenny E. Blau United States 15 989 1.4× 218 0.5× 506 1.5× 478 1.6× 101 0.6× 39 1.5k
Tonny Jensen Denmark 19 800 1.1× 345 0.8× 376 1.1× 138 0.5× 104 0.7× 47 1.5k
Christiane Rüster Germany 13 320 0.4× 495 1.1× 128 0.4× 313 1.1× 107 0.7× 21 1.3k
Ernesto Martín‐Núñez Spain 18 224 0.3× 548 1.3× 180 0.5× 310 1.0× 86 0.5× 51 1.2k
Hans‐Henrik Parving Denmark 15 362 0.5× 283 0.7× 137 0.4× 135 0.5× 92 0.6× 29 844
Marie Frimodt‐Møller Denmark 18 342 0.5× 200 0.5× 181 0.5× 196 0.7× 95 0.6× 60 947
Stephen Zewinger Germany 12 249 0.3× 317 0.7× 247 0.7× 176 0.6× 100 0.6× 22 934
Bruce R. Leslie United States 8 956 1.3× 198 0.5× 471 1.4× 389 1.3× 167 1.0× 16 1.2k
Yoshihito Atsumi Japan 22 608 0.9× 123 0.3× 220 0.6× 324 1.1× 54 0.3× 63 1.2k

Countries citing papers authored by Erik J.M. van Bommel

Since Specialization
Citations

This map shows the geographic impact of Erik J.M. van Bommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik J.M. van Bommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik J.M. van Bommel more than expected).

Fields of papers citing papers by Erik J.M. van Bommel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik J.M. van Bommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik J.M. van Bommel. The network helps show where Erik J.M. van Bommel may publish in the future.

Co-authorship network of co-authors of Erik J.M. van Bommel

This figure shows the co-authorship network connecting the top 25 collaborators of Erik J.M. van Bommel. A scholar is included among the top collaborators of Erik J.M. van Bommel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik J.M. van Bommel. Erik J.M. van Bommel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sridhar, Vikas S., Manuel López Mendoza, David Z.I. Cherney, et al.. (2024). Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications. Clinical Kidney Journal. 18(1). sfae370–sfae370. 2 indexed citations
2.
Baar, Michaël J.B. van, Erik J.M. van Bommel, Daan J. Touw, et al.. (2023). Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function. Kidney International Reports. 8(4). 916–920. 1 indexed citations
3.
4.
Baar, Michaël J.B. van, Erik J.M. van Bommel, Mark M. Smits, et al.. (2022). Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity. Journal of Diabetes and its Complications. 36(4). 108166–108166. 1 indexed citations
5.
Velzen, Daan van, Mark M. Smits, Erik J.M. van Bommel, et al.. (2021). Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function. American Journal of Physiology-Renal Physiology. 320(6). F1152–F1158. 2 indexed citations
6.
Bommel, Erik J.M. van, et al.. (2021). The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis. SHILAP Revista de lepidopterología. 2(3). 537–538. 1 indexed citations
7.
Smits, Mark M., Erik J.M. van Bommel, Marcel H.A. Muskiet, et al.. (2021). Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study. Microcirculation. 28(6). e12700–e12700. 1 indexed citations
8.
Nguyen, Isabella, et al.. (2020). Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors. Kidney International Reports. 5(11). 2052–2054. 3 indexed citations
9.
10.
Bouter, Kristien E., Erik J.M. van Bommel, Hans Jansen, et al.. (2020). The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol. Diabetes Obesity and Metabolism. 22(6). 988–996. 12 indexed citations
11.
Bommel, Erik J.M. van, Mark M. Smits, Marcel H.A. Muskiet, et al.. (2020). Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes. Journal of Hypertension. 38(9). 1811–1819. 22 indexed citations
12.
Bommel, Erik J.M. van, Marcel H.A. Muskiet, Michaël J.B. van Baar, et al.. (2019). The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial. Kidney International. 97(1). 202–212. 253 indexed citations breakdown →
13.
14.
Bommel, Erik J.M. van, Marcel H.A. Muskiet, Michaël J.B. van Baar, et al.. (2019). Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function. Diabetes Care. 43(1). 228–234. 16 indexed citations
15.
Bommel, Erik J.M. van, Hilde Herrema, Mark Davids, et al.. (2019). Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes. Diabetes & Metabolism. 46(2). 164–168. 65 indexed citations
16.
17.
Bommel, Erik J.M. van, Renate T. de Jongh, Annemieke C. Heijboer, et al.. (2018). The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial. Bone. 112. 173–176. 20 indexed citations
18.
Bommel, Erik J.M. van, Marcel H.A. Muskiet, Lennart Tonneijck, et al.. (2017). SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome. Clinical Journal of the American Society of Nephrology. 12(4). 700–710. 172 indexed citations
19.
Tonneijck, Lennart, Marcel H.A. Muskiet, Mark M. Smits, et al.. (2017). Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. Journal of the American Society of Nephrology. 28(4). 1023–1039. 595 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidrun Bosch‐Traberg Breakdown of academic impact, for papers by Jenny E. Blau Breakdown of academic impact, for papers by Tonny Jensen Breakdown of academic impact, for papers by Christiane Rüster Breakdown of academic impact, for papers by Ernesto Martín‐Núñez Breakdown of academic impact, for papers by Hans‐Henrik Parving Breakdown of academic impact, for papers by Marie Frimodt‐Møller Breakdown of academic impact, for papers by Stephen Zewinger Breakdown of academic impact, for papers by Bruce R. Leslie Breakdown of academic impact, for papers by Yoshihito Atsumi
Rankless by CCL
2026